Since the experiment did not design a normal control group but referred to the trend of CTRP3 levels with kidney function changes, it can be speculated that the baseline CTRP3 levels in CKD patients are higher than those in normal people, and this speculation has been confirmed by Yavuz et al. The gene discussed is C1QTNF3; the disease is chronic kidney disease.